1. Clinical comparison of intravenous thrombolysis and bridging artery thrombectomy in hyperacute ischemic stroke with unknown time of onset
- Author
-
Zheng Ping, Bai Qingke, Zhao Zhenguo, and Zhang Jianying
- Subjects
medicine.medical_specialty ,Bridging (networking) ,medicine.diagnostic_test ,Cerebral infarction ,business.industry ,medicine.medical_treatment ,Magnetic resonance imaging ,General Medicine ,Thrombolysis ,cerebral infarction ,medicine.disease ,solitaire thrombectomy ,medicine.anatomical_structure ,Internal medicine ,Ischemic stroke ,Research Letter ,medicine ,Cardiology ,magnetic resonance imaging ,intravenous thrombolysis ,cardiovascular diseases ,large intracranial artery occlusion ,business ,Artery - Abstract
IntroductionThe aim of the study was to explore the clinical efficacy and safety of intravenous thrombolysis and bridging artery thrombectomy for hyperacute ischemic stroke with unknown onset time.Material and methodsOne hundred and twenty-eight patients with hyperacute cerebral infarction and without a clear time of onset were randomly divided into intravenous thrombolysis (n = 66) and bridging artery thrombectomy groups (n = 62).ResultsIn the intravenous thrombolysis group, 37 patients’ vessels had recanalization, 32 patients’ 24-hour National Institute of Health Stroke Scale (NIHSS) score improved, and 42 patients’ 90-day modified Rankin Scale (mRS) score was good. In the bridging artery thrombectomy group, 62 patients’ vessels had recanalization, 28 patients’ 24-hour NIHSS score improved, and 38 patients’ 90-day mRS score was good.ConclusionsThe benefits and adverse events between intravenous thrombolysis and bridging artery thrombectomy for ischemic stroke with unknown time of onset are similar.
- Published
- 2021